Top

CardioVascular and Interventional Radiology

Published in:

Open Access 01-10-2018 | OTHERS

Radioembolisation in Europe: A Survey Amongst CIRSE Members

Published in: CardioVascular and Interventional Radiology | Issue 10/2018

Abstract

Introduction

Radioembolisation of liver tumours demands many choices from the physician regarding planning of treatment and subsequent follow-up.

Methods

An online questionnaire was distributed amongst all members of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) to investigate the current state of radioembolisation practice.

Results

The survey was completed by 60 centres. The increasing number of radioembolisation procedures may reflect that radioembolisation is increasingly recognised as a valuable treatment option in European cancer guidelines. Imaging modalities play an important role in decision making. Furthermore, there seems to be a trend towards less coil-embolisation of non-target vessels. In addition, type of microsphere, model for dose calculation, complications and future developments are evaluated in this article.

Conclusions

This survey provides insight into the current state of radioembolisation practice across Europe.

Available only for authorised users

Ahmadzadehfar H, Biersack HJ, Ezziddin S. Radioembolization of liver tumors with yttrium-90 microspheres. Semin Nucl Med. 2010;40(2):105–21. https://doi.org/10.1053/j.semnuclmed.2009.11.001.CrossRefPubMed

Dezso K, Bugyik E, Papp V, Laszlo V, Dome B, Tovari J, et al. Development of arterial blood supply in experimental liver metastases. Am J Pathol. 2009;175(2):835–43. https://doi.org/10.2353/ajpath.2009.090095.CrossRefPubMedPubMedCentral

Salem R, Mazzaferro V, Sangro B. Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons, current challenges, and clinical perspectives. Hepatology. 2013;58(6):2188–97. https://doi.org/10.1002/hep.26382.CrossRefPubMed

Powerski MJ, Scheurig-Munkler C, Banzer J, Schnapauff D, Hamm B, Gebauer B. Clinical practice in radioembolization of hepatic malignancies: a survey among interventional centres in Europe. Eur J Radiol. 2012;81(7):e804–11. https://doi.org/10.1016/j.ejrad.2012.04.004.CrossRefPubMed

van den Hoven AF, Prince JF, de Keizer B, Vonken EJ, Bruijnen RC, Verkooijen HM, et al. Use of C-arm cone beam CT during hepatic radioembolization: protocol optimization for extrahepatic shunting and parenchymal enhancement. Cardiovasc Intervent Radiol. 2016;39(1):64–73. https://doi.org/10.1007/s00270-015-1146-8.CrossRefPubMed

Powerski M, Busse A, Seidensticker M, Fischbach F, Seidensticker R, Strach K, et al. Prophylactic embolization of the cystic artery prior to radioembolization of liver malignancies–an evaluation of necessity. Cardiovasc Intervent Radiol. 2015;38(3):678–84. https://doi.org/10.1007/s00270-015-1088-1.CrossRefPubMed

Prince JF, van den Hoven AF, van den Bosch MA, Elschot M, de Jong HW, Lam MG. Radiation-induced cholecystitis after hepatic radioembolization: do we need to take precautionary measures? J Vasc Interv Radiol. 2014;25(11):1717–23. https://doi.org/10.1016/j.jvir.2014.06.024.CrossRefPubMed

Braat MN, van Erpecum KJ, Zonnenberg BA, van den Bosch MA, Lam MG. Radioembolization-induced liver disease: a systematic review. Eur J Gastroenterol Hepatol. 2017;29(2):144–52. https://doi.org/10.1097/meg.0000000000000772.CrossRefPubMed

Gil-Alzugaray B, Chopitea A, Inarrairaegui M, Bilbao JI, Rodriguez-Fraile M, Rodriguez J, et al. Prognostic factors and prevention of radioembolization-induced liver disease. Hepatology. 2013;57(3):1078–87. https://doi.org/10.1002/hep.26191.CrossRefPubMed

10.

Elschot M, Nijsen JF, Lam MG, Smits ML, Prince JF, Viergever MA, et al. ((9)(9)m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with (1)(6)(6)Ho-microspheres. Eur J Nucl Med Mol Imaging. 2014;41(10):1965–75. https://doi.org/10.1007/s00259-014-2784-9.CrossRefPubMed

11.

Haste P, Tann M, Persohn S, LaRoche T, Aaron V, Mauxion T, et al. Correlation of technetium-99 m macroaggregated albumin and yttrium-90 glass microsphere biodistribution in hepatocellular carcinoma: a retrospective review of pretreatment single photon emission CT and posttreatment positron emission tomography/CT. J Vasc Interv Radiol. 2017;28(5):722–30. https://doi.org/10.1016/j.jvir.2016.12.1221.CrossRefPubMed

12.

Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, et al. 99 mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. J Nucl Med. 2013;54(8):1294–301. https://doi.org/10.2967/jnumed.112.117614.CrossRefPubMed

Title: Radioembolisation in Europe: A Survey Amongst CIRSE Members
Publication date: 01-10-2018
Published in: CardioVascular and Interventional Radiology / Issue 10/2018
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-018-1982-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Radioembolisation in Europe: A Survey Amongst CIRSE Members

Abstract

Introduction

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2018

Regarding “Percutaneous Antegrade Colonic Stent Insertion Using a Proximal Trans-peritoneal Colopexy Technique”

CT-Guided Microwave Ablation of Liver Tumors in Anatomically Challenging Locations

Microwave Ablation in the Management of Colorectal Cancer Pulmonary Metastases

Could Monopolar Mode be a Suitable Strategy of Energy Deposition for Performing No-Touch Radiofrequency Ablation of Liver Tumor ≤ 5 cm?

Patient-Reported Outcomes of Bleomycin Sclerotherapy for Low-Flow Vascular Malformations and Predictors of Improvement

Incidence and Endovascular Treatment of Isolated Atherosclerotic Popliteal Artery Disease: Outcomes from the IPAD Multicenter Study